메뉴 건너뛰기




Volumn 144, Issue , 2014, Pages

Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: A placebo-controlled, double-blind, randomised study

Author keywords

Bipolar disorder; Celecoxib; Clinical trial; COX II inhibitor; Inflammatory cytokines

Indexed keywords

C REACTIVE PROTEIN; CELECOXIB; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LITHIUM; PLACEBO; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID; BIOLOGICAL MARKER; CYCLOOXYGENASE 2 INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

EID: 84899756560     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.13880     Document Type: Article
Times cited : (22)

References (40)
  • 1
    • 84875219908 scopus 로고    scopus 로고
    • Prevalence, correlates, comorbidity and severity of bipolar disorder: Results from the Singapore Mental Health Study
    • Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J Affect Disord. 2013;146(2):189-96.
    • (2013) J Affect Disord , vol.146 , Issue.2 , pp. 189-196
    • Subramaniam, M.1    Abdin, E.2    Vaingankar, J.A.3    Chong, S.A.4
  • 2
    • 77956262711 scopus 로고    scopus 로고
    • Symptoms and signs of the initial prodrome of bipolar disorder: A systematic review
    • Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: A systematic review. J Affect Disord. 2010;126(1-2):1-13.
    • (2010) J Affect Disord , vol.126 , Issue.1-2 , pp. 1-13
    • Skjelstad, D.V.1    Malt, U.F.2    Holte, A.3
  • 5
    • 0035062306 scopus 로고    scopus 로고
    • Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania
    • Tsai SYM, Yang YY, Kuo CJ, Chen CC, Leu SJC. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2001;64(2):185-93.
    • (2001) J Affect Disord , vol.64 , Issue.2 , pp. 185-193
    • Tsai, S.Y.M.1    Yang, Y.Y.2    Kuo, C.J.3    Chen, C.C.4    Leu, S.J.C.5
  • 6
    • 72649084925 scopus 로고    scopus 로고
    • Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
    • Brietzke E, Kauer-Sant'Anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder. Brain Behav Immun. 2009;23(8):1079-82.
    • (2009) Brain Behav Immun , vol.23 , Issue.8 , pp. 1079-1082
    • Brietzke, E.1    Kauer-SanT'Anna, M.2    Teixeira, A.L.3    Kapczinski, F.4
  • 7
    • 84873279865 scopus 로고    scopus 로고
    • The role of the innate immune system in psychiatric disorders
    • Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Molecular and Cellular Neuroscience. 2013;53:52-62.http://dx.doi.org/ 10.1016/j.mcn.2012.10.002
    • (2013) Molecular and Cellular Neuroscience , vol.53 , pp. 52-62
    • Jones, K.A.1    Thomsen, C.2
  • 9
    • 35948958993 scopus 로고    scopus 로고
    • Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
    • DOI 10.1016/j.jad.2007.02.018, PII S0165032707000912
    • Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104(1):91-5. (Pubitemid 350064526)
    • (2007) Journal of Affective Disorders , vol.104 , Issue.1-3 , pp. 91-95
    • Kim, Y.-K.1    Jung, H.-G.2    Myint, A.-M.3    Kim, H.4    Park, S.-H.5
  • 10
    • 34247490138 scopus 로고    scopus 로고
    • Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
    • DOI 10.1016/j.pnpbp.2007.02.018, PII S0278584607000772
    • Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(4):952-5. (Pubitemid 46660310)
    • (2007) Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.31 , Issue.4 , pp. 952-955
    • Dickerson, F.1    Stallings, C.2    Origoni, A.3    Boronow, J.4    Yolken, R.5
  • 11
    • 31844457040 scopus 로고    scopus 로고
    • Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
    • DOI 10.1016/j.jad.2005.11.015, PII S0165032705003484
    • O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006;90(2):263-7. (Pubitemid 43183536)
    • (2006) Journal of Affective Disorders , vol.90 , Issue.2-3 , pp. 263-267
    • O'Brien, S.M.1    Scully, P.2    Scott, L.V.3    Dinan, T.G.4
  • 13
    • 84858287588 scopus 로고    scopus 로고
    • Electroconvulsive therapy (ECT) in bipolar disorder: A narrative review of literature
    • Thirthalli J, Prasad MK, Gangadhar BN. Electroconvulsive therapy (ECT) in bipolar disorder: A narrative review of literature. Asian J Psychiatr. 2012;5(1):11-7.
    • (2012) Asian J Psychiatr , vol.5 , Issue.1 , pp. 11-17
    • Thirthalli, J.1    Prasad, M.K.2    Gangadhar, B.N.3
  • 16
    • 70249087363 scopus 로고    scopus 로고
    • Response to ECT in bipolar I, bipolar II and unipolar depression
    • Medda P, Perugi G, Zanello S, Ciuffa M, Cassano G. Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord. 2009;118(1-3):55.
    • (2009) J Affect Disord , vol.118 , Issue.1-3 , pp. 55
    • Medda, P.1    Perugi, G.2    Zanello, S.3    Ciuffa, M.4    Cassano, G.5
  • 18
    • 79958134275 scopus 로고    scopus 로고
    • Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques
    • Loo C, Katalinic N, Mitchell PB, Greenberg B. Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord. 2011;132(1):1-13.
    • (2011) J Affect Disord , vol.132 , Issue.1 , pp. 1-13
    • Loo, C.1    Katalinic, N.2    Mitchell, P.B.3    Greenberg, B.4
  • 19
    • 0346914336 scopus 로고    scopus 로고
    • Raised Plasma Levels of Tumor Necrosis Factor [alpha] in Patients with Depression: Normalization during Electroconvulsive Therapy
    • DOI 10.1097/00124509-200312000-00002
    • Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised Plasma Levels of Tumor Necrosis Factor [alpha] in Patients With Depression: Normalization During Electroconvulsive Therapy. J ECT. 2003;19(4):183-8. (Pubitemid 38018294)
    • (2003) Journal of ECT , vol.19 , Issue.4 , pp. 183-188
    • Hestad, K.A.1    Tonseth, S.2    Stoen, C.D.3    Ueland, T.4    Aukrust, P.5
  • 20
    • 34248169336 scopus 로고    scopus 로고
    • Electroconvulsive therapy: A review of history, patient selection, technique, and medication management
    • DOI 10.1097/SMJ.0b013e318038fce0, PII 0000761120070500000013
    • Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100(5):494-8. (Pubitemid 46707451)
    • (2007) Southern Medical Journal , vol.100 , Issue.5 , pp. 494-498
    • Taylor, S.1
  • 21
    • 79955916722 scopus 로고    scopus 로고
    • Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder
    • Fluitman SB, Heijnen CJ, Denys DAJP, Nolen WA, Balk FJ, Westenberg HGM. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord. 2011;131(1):388-92.
    • (2011) J Affect Disord , vol.131 , Issue.1 , pp. 388-392
    • Fluitman, S.B.1    Heijnen, C.J.2    Denys, D.A.J.P.3    Nolen, W.A.4    Balk, F.J.5    Westenberg, H.G.M.6
  • 22
    • 0036319011 scopus 로고    scopus 로고
    • Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage
    • Mastbergen S, Lafeber F, Bijlsma J. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford). 2002;41(7):801-8. (Pubitemid 34822964)
    • (2002) Rheumatology , vol.41 , Issue.7 , pp. 801-808
    • Mastbergen, S.C.1    Lafeber, F.P.J.G.2    Bijlsma, J.W.J.3
  • 24
    • 84861460724 scopus 로고    scopus 로고
    • Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial
    • Fields C, Drye L, Vaidya V, Lyketsos C. Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial. American Journal of Geriatric Psych. 2012;20(6):505.
    • (2012) American Journal of Geriatric Psych , vol.20 , Issue.6 , pp. 505
    • Fields, C.1    Drye, L.2    Vaidya, V.3    Lyketsos, C.4
  • 25
    • 33846620518 scopus 로고    scopus 로고
    • Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    • DOI 10.1016/j.schres.2006.11.016, PII S0920996406004956
    • Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr Res. 2007;90(1-3):179-85. (Pubitemid 46177578)
    • (2007) Schizophrenia Research , vol.90 , Issue.1-3 , pp. 179-185
    • Akhondzadeh, S.1    Tabatabaee, M.2    Amini, H.3    Ahmadi, A.S.A.4    Abbasi, S.H.5    Behnam, B.6
  • 27
    • 49149090886 scopus 로고    scopus 로고
    • Celecoxib potently inhibits TNFα-induced nuclear translocation and activation of NF-κB
    • Funakoshi-Tago M, Shimizu T, Tago K, Nakamura M, Itoh H, Sonoda Y, et al. Celecoxib potently inhibits TNFα-induced nuclear translocation and activation of NF-κB. Biochem Pharmacol. 2008;76(5):662-71.
    • (2008) Biochem Pharmacol , vol.76 , Issue.5 , pp. 662-671
    • Funakoshi-Tago, M.1    Shimizu, T.2    Tago, K.3    Nakamura, M.4    Itoh, H.5    Sonoda, Y.6
  • 28
    • 20444405296 scopus 로고    scopus 로고
    • Celecoxib augmentation of continuously Ill patients with schizophrenia
    • DOI 10.1016/j.biopsych.2005.02.024, PII S0006322305001897
    • Rapaport MH, Delrahim KK, Bresee CJ, Maddux RE, Ahmadpour O, Dolnak D. Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia. Biol Psychiatry. 2005;57(12):1594-6. (Pubitemid 40805391)
    • (2005) Biological Psychiatry , vol.57 , Issue.12 , pp. 1594-1596
    • Rapaport, M.H.1    Delrahim, K.K.2    Bresee, C.J.3    Maddux, R.E.4    Ahmadpour, O.5    Dolnak, D.6
  • 29
    • 77955050321 scopus 로고    scopus 로고
    • Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
    • Müller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010;121(1-3):118.
    • (2010) Schizophr Res , vol.121 , Issue.1-3 , pp. 118
    • Müller, N.1    Krause, D.2    Dehning, S.3    Musil, R.4    Schennach-Wolff, R.5    Obermeier, M.6
  • 30
    • 40549126636 scopus 로고    scopus 로고
    • Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study
    • DOI 10.1002/hup.912
    • Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol. 2008;23(2):87-94. (Pubitemid 351359580)
    • (2008) Human Psychopharmacology , vol.23 , Issue.2 , pp. 87-94
    • Nery, F.G.1    Monkul, E.S.2    Hatch, J.P.3    Fonseca, M.4    Zunta-Soares, G.B.5    Frey, B.N.6    Bowden, C.L.7    Soares, J.C.8
  • 31
    • 80053446003 scopus 로고    scopus 로고
    • A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder
    • Sayyah M, Boostani H, Pakseresht S, Malayeri A. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):403-6.
    • (2011) Psychiatry Res , vol.189 , Issue.3 , pp. 403-406
    • Sayyah, M.1    Boostani, H.2    Pakseresht, S.3    Malayeri, A.4
  • 32
    • 67650083320 scopus 로고    scopus 로고
    • Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial
    • Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607-11.
    • (2009) Depress Anxiety , vol.26 , Issue.7 , pp. 607-611
    • Akhondzadeh, S.1    Jafari, S.2    Raisi, F.3    Nasehi, A.A.4    Ghoreishi, A.5    Salehi, B.6
  • 33
    • 84867582069 scopus 로고    scopus 로고
    • Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
    • Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012; 141(2-3):308-14.
    • (2012) J Affect Disord , vol.141 , Issue.2-3 , pp. 308-314
    • Abbasi, S.H.1    Hosseini, F.2    Modabbernia, A.3    Ashrafi, M.4    Akhondzadeh, S.5
  • 35
    • 41849105075 scopus 로고    scopus 로고
    • Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder
    • DOI 10.1097/YCT.0b013e3181571abb, PII 0012450920080300000015
    • Lehtimäki K, Keränen T, Huuhka M, Palmio J, Hurme M, Leinonen E, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 2008;24(1):88-91. (Pubitemid 351498648)
    • (2008) Journal of ECT , vol.24 , Issue.1 , pp. 88-91
    • Lehtimaki, K.1    Keranen, T.2    Huuhka, M.3    Palmio, J.4    Hurme, M.5    Leinonen, E.6    Peltola, J.7
  • 36
    • 33846856622 scopus 로고    scopus 로고
    • C-reactive protein (CRP)-lowering agents
    • DOI 10.1111/j.1527-3466.2006.00033.x
    • Prasad K. C-Reactive Protein (CRP)-Lowering Agents. Cardiovasc Drug Rev. 2006;24(1):33-50. (Pubitemid 46722293)
    • (2006) Cardiovascular Drug Reviews , vol.24 , Issue.1 , pp. 33-50
    • Prasad, K.1
  • 37
    • 0037469296 scopus 로고    scopus 로고
    • Selective COX-2 inhibition improves endothelial function in coronary artery disease
    • Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation. 2003;107(3):405-9.
    • (2003) Circulation , vol.107 , Issue.3 , pp. 405-409
    • Chenevard, R.1    Hürlimann, D.2    Béchir, M.3    Enseleit, F.4    Spieker, L.5    Hermann, M.6
  • 38
    • 0242460486 scopus 로고    scopus 로고
    • Effect of Cyclooxygenase-2 Inhibition with Rofecoxib on Endothelial Dysfunction and Inflammatory Markers in Patients with Coronary Artery Disease
    • DOI 10.1016/j.jacc.2003.05.006
    • Title LM, Giddens K, McInerney MM, McQueen MJ, Nassar BA. Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease. J Am Coll Cardiol. 2003;42(10):1747-53. (Pubitemid 37433652)
    • (2003) Journal of the American College of Cardiology , vol.42 , Issue.10 , pp. 1747-1753
    • Title, L.M.1    Giddens, K.2    McInerney, M.M.3    McQueen, M.J.4    Nassar, B.A.5
  • 39
    • 24644475268 scopus 로고    scopus 로고
    • Effect of celecoxib, a cyclooxygenase-2-specific inhibitor, on insulin sensitivity, C-reactive protein, homocysteine, and metabolic profile in overweight or obese subjects
    • DOI 10.1089/met.2005.3.95
    • González-Ortiz M, Pascoe-González S, Kam-Ramos AM, Hernández-Salazar E. Effect of celecoxib, a cyclooxygenase-2-specific inhibitor, on insulin sensitivity, C-reactive protein, homocysteine, and metabolic profile in overweight or obese subjects. Metab Syndr Relat Disord. 2005;3(2):95-101. (Pubitemid 41269267)
    • (2005) Metabolic Syndrome and Related Disorders , vol.3 , Issue.2 , pp. 95-101
    • Gonzalez-Ortiz, M.1    Pascoe-Gonzalez, S.2    Martinez-Abundis, E.3    Kam-Ramos, A.M.4    Hernandez-Salazar, E.5
  • 40
    • 84868133575 scopus 로고    scopus 로고
    • Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: A meta-analysis of randomized controlled trials
    • Tarp S, Bartels EM, Bliddal H, Furst DE, Boers M, Danneskiold- Samsøe B, et al. Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: A meta-analysis of randomized controlled trials. Arthritis Rheum. 2012;64(11):3511-21.
    • (2012) Arthritis Rheum , vol.64 , Issue.11 , pp. 3511-3521
    • Tarp, S.1    Bartels, E.M.2    Bliddal, H.3    Furst, D.E.4    Boers, M.5    Danneskiold- Samsøe, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.